26-04-2017 EPO - European Inventor Award 2017 finalists announced

European Inventor Award 2017

The nominated inventors fight disease, take on some of the most pressing environmental issues and enrich our daily lives. The fifteen finalists for the European Inventor Award 2017, announced today by the European Patent Office (EPO), have strongly contributed to advancing technology and generating economic value and employment in Europe and beyond.

Read more, click here

In the Research category, Sylviane Muller represents France, click here
French immunologist Sylviane Muller at the National Centre for Scientific Research (CNRS) pioneered the first treatment of its kind for the autoimmune disease known as systemic lupus erythematosus (SLE). Muller identified so-called CD4 T-cells as the main trigger behind lupus, and she discovered and synthesised a molecule which halts the progression of the disease, without supressing the body's immune system as other treatments do. Muller’s innovations led to the development of the drug Lupuzor, which will be marketed through her start-up company ImmuPharma with an expected launch in 2018.

Source EPO